Tailored Toxicity-Driven Administration of Vismodegib in Patients With Multiple or Locally Advanced Basal Cell Carcinoma: A Pilot Analysis

In this pilot study, we describe our experience with vismodegib in the treatment of basal cell carcinoma (BCC) and evaluate the feasibility of a tailored toxicity-driven administration of vismodegib in patients with multiple or locally advanced BCC. We retrospectively analyzed the clinical charts of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tronconi, Maria Chiara, Solferino, Alessandra, Giordano, Laura, Borroni, Riccardo, Mancini, Luca, Santoro, Armando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691528/
https://www.ncbi.nlm.nih.gov/pubmed/33282729
http://dx.doi.org/10.3389/fonc.2020.563404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7691528/
https://www.ncbi.nlm.nih.gov/pubmed/33282729
http://dx.doi.org/10.3389/fonc.2020.563404

Ejemplares similares